Reuters logo
BRIEF-Hikma Pharma estimates 2013 revenue growth of 23 pct
February 14, 2014 / 7:21 AM / 4 years ago

BRIEF-Hikma Pharma estimates 2013 revenue growth of 23 pct

Feb 14 (Reuters) - Hikma Pharmaceuticals PLC : * Revenue growth for the full year will now be around 23 pct, ahead of our previous guidance * Our global injectables business has performed very well, with revenue growth of around 14 pct * Source text for Eikon: * For more news, please click here

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below